| Product NDC: | 10631-096 |
| Proprietary Name: | HALOG |
| Non Proprietary Name: | HALCINONIDE |
| Active Ingredient(s): | 1 mg/g & nbsp; HALCINONIDE |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10631-096 |
| Labeler Name: | Ranbaxy Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017824 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090519 |
| Package NDC: | 10631-096-15 |
| Package Description: | 15 g in 1 TUBE (10631-096-15) |
| NDC Code | 10631-096-15 |
| Proprietary Name | HALOG |
| Package Description | 15 g in 1 TUBE (10631-096-15) |
| Product NDC | 10631-096 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | HALCINONIDE |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20090519 |
| Marketing Category Name | NDA |
| Labeler Name | Ranbaxy Laboratories Inc. |
| Substance Name | HALCINONIDE |
| Strength Number | 1 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |